1Y Annualised Return
▲31.91%
3Y Annualised Return
▲35.53%
5Y Annualised Return
▲88.35%
Beta Drugs Stock Performance
|
|
|
Beta Drugs Company background
Founded in: 2005
Managing director: Varun Batra
Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to Beta Drugs Limited on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Companys products range from anticancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new state of the art manufacturing facility for oncology formulations in 2014 developed inhouse Albumin bound Paclitaxel in 2015 started inhouse API Plant Adley Labs in 2017. In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEMRTU, ADLEAP, ADLANTE, BEXINIB launched 1st Indian Brand of Dasatinib, BEEDAN. In 2025, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
Beta Drugs Share Price Today
As of 18 Oct 2025, Beta Drugs share price is ₹1788. The stock opened at ₹1758 and had closed at ₹1747.6 the previous day. During today’s trading session, Beta Drugs share price moved between ₹1,758.00 and ₹1,789.00, with an average price for the day of ₹1773.50. Over the last 52 weeks, the stock has recorded a low of ₹1,429.52 and a high of ₹2,215.24. In terms of performance, Beta Drugs share price has declined by 4% over the past six months and has increased by 31.91% over the last year.
Beta Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹51,02,611 in 5 years with a gain of ₹48,02,611 (+1600.87%)
Beta Drugs Fundamental
Market Cap (in crs)
1,804.91
Face Value
10
Turnover (in lacs)
31.92
Key Metrics
Qtr Change %
25.08% Gain from 52W Low
3.9
Dividend yield 1yr %
0
Beta Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1788
Current Price
5Day EMA
1,751.80
10Day EMA
1,755.80
12Day EMA
1,760.00
20Day EMA
1,776.60
26Day EMA
1,785.80
50Day EMA
1,800.60
100Day EMA
1,801.10
200Day EMA
1,766.40
5Day SMA
1,736.40
10Day SMA
1,745.10
20Day SMA
1,783.10
30Day SMA
1,806.00
50Day SMA
1,834.10
100Day SMA
1,802.00
150Day SMA
1,803.40
200Day SMA
1,790.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1680 Rs | 1785 Rs |
Week Rs | 1890 Rs | 2520 Rs |
Month Rs | 2480 Rs | 3265 Rs |
Resistance & Support
1,778.33
Pivot
Resistance
First Resistance
1,798.67
Second Resistance
1,809.33
Third Resistance
1,829.67
Support
First Support
1,767.67
Second support
1,747.33
Third Support
1,736.67
Relative Strength Index
50.19
Money Flow Index
40.78
MACD
-25.85
MACD Signal
-24.70
Average True Range
43.80
Average Directional Index
18.48
Rate of Change (21)
-1.80
Rate of Change (125)
-6.47
Beta Drugs Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
721.25 | 2,085.18 | 544.1 | 842.9 | 699.15 | 2.34% | -5.72% | 7.15% | -6.34% | 1.58% | 0.64% | 38.14 | 40.71 | 6.37 | |
152.08 | 1,606.72 | 106.04 | 190.97 | 152.53 | -4.47% | -0.47% | 21.79% | 16.57% | 108.04% | 0.33% | 22.78 | 40.71 | 1.52 | |
875.95 | 2,162.79 | 744.95 | 1139 | 862.95 | 0.55% | -2.32% | 7.11% | -21.12% | 30.82% | 2.85% | 21.04 | 40.71 | 2.76 | |
16.37 | 1,538.78 | 14.1 | 23.87 | 16.44 | -3.65% | -9.06% | -6.78% | -19.87% | 0.00% | 0.00% | 26.82 | 40.71 | 4.52 | |
37.23 | 1,630.23 | 5.75 | 37.23 | 36.50 | 10.34% | 23.93% | 90.92% | 412.81% | 3,379.44% | 0.03% | 161.87 | 40.71 | 25.94 | |
927.20 | 1,954.28 | 665.1 | 1198.25 | 921.75 | 1.38% | -4.71% | -14.47% | -7.20% | 294.39% | 0.62% | 30.18 | 40.71 | 3.87 |
Beta Drugs Latest News
Beta Drugs Share Price FAQs
How has Beta Drugs shares performed in the past ?
Beta Drugs share price in the past 1-year return was -3.22. The Beta Drugs share hit a 1-year low of Rs. 1429.52 and a 1-year high of Rs. 2215.24.
What is the market cap of Beta Drugs ?
The market cap of Beta Drugs is Rs. 1804.91 Cr. as of 17/10/2025.
What is the current P/E ratio of Beta Drugs ?
The PE ratios of Beta Drugs is 96.23 as of 17/10/2025.
What is the current PB ratio of Beta Drugs ?
The PB ratios of Beta Drugs is 13.98 as of 17/10/2025
How to buy Beta Drugs shares?
You can easily buy Beta Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Beta Drugs ?
The 52-week high and low of Beta Drugs share price is ₹2215.24 and ₹1429.52 as of 17/10/2025.
Please be aware that Beta Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Beta Drugs